SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: tdinovo who wrote (186)11/3/1997 9:25:00 AM
From: Larry Liebman  Read Replies (2) | Respond to of 353
 
This looks to be a good deal for ARRS. If the deal is at $167 million, with SQNA having assets of $50 million+, and $103 million potentialy from Parke-Davis today, you're looking at a relatively small amount being paid for the on-going collaborations and future considerations. As usual, I am interested how the corporate "cultures" abide or collide. I've been surprised over this year that there haven't been more take-overs, mergers, etc.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News